Rapid changes in the pharmaceutical and drug development fields require a dedicated team of experts. Our consulting experience includes applying actuarial principles to health economics challenges for both pharmaceuticals and medical devices and builds on the support of in-house health economists and clinicians. Our areas of research draw on real-world evidence and outcomes data.